
March/April 2019—A daily adequate dose of healthy sleep is the most effective performance enhancement on the planet.
March/April 2019—Sleep disorders are a common symptom of traumatic brain injury and treating them is also part of promoting recovery.
March/April 2019—New treatments hold promise of increasing efficacy with precision medicine.
March/April 2019—This sleep disorder is a strong predictor for the development of synucleinopathies, including Parkinson’s disease, multiple system atrophy, and dementia with Lewy bodies.
Monday, March 18, 2019— Research published in Current Biologyshows that sleeping on the weekends to make up for lost sleep during the week has no beneficial effect for adults. In this …
Tuesday, March 12, 2019—The Food and Drug Administration (FDA) accepted a New Drug Application (NDA) for lemborexant (Eisai, Woodcliff Lake, NJ). Lemborexant is novel small molecule being investigate…
Tuesday, March 05, 2019—In a large multicenter study of 1,280 patients diagnosed with rapid eye movement (REM) sleep behavior disorder (RBD), published in Brain, patients’ scores on motor …
Wednesday, February 13, 2019—Pitolisant (Harmony Biosciences; Plymouth Meeting, PA), an investigational drug being studied for the treatment of excessive daytime sleepiness and/or cataplexy in patients wi…
For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com
Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.
We use cookies to offer a better user experience and to analyze site traffic. To comply with the European General Data Protection Regulation (GDPR), we are implementing a cookie consent manager to provide residents of the EU/EEA with the ability to customize their cookies. Until this is available, your continued use of this site will be deemed as consent to use of cookies.
Continue »